NIOCORP DEVELOPMENTS LTD current report, 14 September 2018

Business Context and Reporting Period

NioCorp Developments Ltd., a British Columbia corporation, filed this Form 8-K on September 14, 2018, to report the closing of the first tranche of a non-brokered private placement. The company is an emerging growth company.

Key Financial Metrics

The filing details a capital raise event rather than periodic operating results. Key metrics from the transaction include:

  • Gross Proceeds: C$1.84 million.
  • Units Issued: 2,917,587 Units.
  • Price per Unit: C$0.63.
  • Warrant Terms: Each Unit includes one-half of a warrant exercisable for one Common Share at C$0.75, expiring September 14, 2020.
  • Maximum Warrants: Up to 3,200,000 Warrants issuable under the Warrant Indenture.

The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity positions outside of the proceeds from this specific transaction.

Material Changes

The primary material change is the increase in equity capital and the issuance of unregistered securities. The company entered into Subscription Agreements and a Warrant Indenture with Computershare Trust Company of Canada. This represents a significant change in the company's capital structure compared to the prior period.

Guidance, Outlook, and Risks

The filing does not contain forward-looking guidance, management commentary on future operations, or specific risk factors beyond standard legal representations. The transaction was executed under exemptions from registration requirements (Regulation S and Rule 506(b) of Regulation D). The Warrant Indenture includes provisions for adjustments to the exercise price and share count in the event of subdivisions, consolidations, or reclassifications of Common Shares.

Investor Verification Checklist

  • Verify the total number of Units issued in subsequent tranches, if any, to determine the full capital raised.
  • Confirm the current cash balance and burn rate to assess the runway provided by the C$1.84 million proceeds.
  • Review the full text of the Subscription Agreement (Exhibit 4.1) and Warrant Indenture (Exhibit 4.2) for specific covenants or restrictions.
  • Monitor the exercise price of C$0.75 relative to the current trading price of the Common Shares to gauge warrant dilution potential.